114 results
Page 2 of 6
SC14D9C
EX-99.7
h110zkv5rjq77v44
3 Oct 23
Written communication relating to third party tender offer
5:24pm
SC14D9C
EX-99.6
gwfx3 6ga
3 Oct 23
Written communication relating to third party tender offer
5:24pm
SC TO-C
oi4pqyov407oubpb gt
3 Oct 23
Information about tender offer
4:30pm
SC TO-C
EX-99.1
sq6p 0vp0p0ovgw
3 Oct 23
Information about tender offer
4:30pm
SC14D9C
EX-99.4
cogk5e6x
3 Oct 23
Written communication relating to third party tender offer
7:37am
SC14D9C
bneiyg8
3 Oct 23
Written communication relating to third party tender offer
7:37am
SC14D9C
EX-2.1
crvxjwjjs 9xq1ul
3 Oct 23
Written communication relating to third party tender offer
7:37am
8-K
EX-2.1
4w6p2zm2pnpiqn
3 Oct 23
Tender and Support Agreement
7:35am
8-K
EX-99.4
3qk bmkm1xcm
3 Oct 23
Tender and Support Agreement
7:35am
8-K
mkfei
3 Oct 23
Tender and Support Agreement
7:35am
ARS
liy8dcr
1 May 23
Annual report to shareholders
1:52pm
8-K
EX-1.1
63ify20nw a6cc8l4
14 Sep 22
POINT Biopharma Prices Public Offering of Common Stock
4:14pm